Pimera was founded by Denis Drygin, Mustapha Haddach, Ph.D., Denis Drygin, Ph.D..

How much funding has Pimera raised?

Pimera has disclosed $2.2M raised across 1 round.

Where is Pimera headquartered?

Pimera is headquartered in San Diego, US.

Pimera

San Diego, US · Delaware corporation

Find your way into Pimera

Each arrow is one introduction. Sign up to fill in the first one.

104 people can intro you to Denis

Ask Sudhir Agrawal to introduce you to Denis Drygin

You →Sudhir · together at Haya Therapeutics →Denis

Your email: who you already know at Pimera, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pimera team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Pimera is a privately held biopharmaceutical company developing small-molecule cancer therapeutics, including RNA polymerase I inhibitors that activate nucleolar stress to treat hematologic and other cancers. It focuses on oncology drug discovery and development.

Biotech Healthtech

Founders & leadership

Denis Drygin Founder (former VP of R&D)Denis Drygin is a biotech scientist and executive with over two decades of experience in oncology drug discovery; he previously led preclinical and discovery efforts across multiple therapeutic programs at other companies and holds numerous patents and peer-reviewed publications in the field.

Mustapha Haddach, Ph.D.President & CEO, Founder, Board Member

Denis Drygin, Ph.D.Founder, Board Member

Brian T. DorseyChief Development Officer (CDO)

Mustapha HaddachFounder, President & CEO

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 1 round · 2020

▶$2.2MraisedMay 2020 · 13 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Mustapha HaddachExecutive Officer, Director

Offering amount: $6.5M
Amount sold: $2.2M
First sale: Feb 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

DecipheraDeciphera is a pharmaceutical company focused on developing treatments for people living with cancer. Its work centers on oncology drug development and support for patient communities.

Chimera BioengineeringChimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.

Companies working in the same space as Pimera.

Frequently asked questions

What does Pimera do?: Pimera is a privately held biopharmaceutical company developing small-molecule cancer therapeutics, including RNA polymerase I inhibitors that activate nucleolar stress to treat hematologic and other cancers. It focuses on oncology drug discovery and development.
Who founded Pimera?: Pimera was founded by Denis Drygin, Mustapha Haddach, Ph.D., Denis Drygin, Ph.D..
How much funding has Pimera raised?: Pimera has disclosed $2.2M raised across 1 round.
Where is Pimera headquartered?: Pimera is headquartered in San Diego, US.